ENvue Medical (FEED) Net Margin (2014 - 2026)

ENvue Medical (FEED) has 13 years of Net Margin data on file, last reported at 3464.17% in Q1 2026.

• On a quarterly basis, Net Margin fell 328153.0% year-over-year to 3464.17% in Q1 2026; TTM through Mar 2026 was 1720.5%, a 153308.0% decrease from a year earlier, with the FY2025 full-year figure at 657.07%, down 51223.0% from the prior year.
• Net Margin for Q1 2026 stood at 3464.17%, up from 4366.35% in the prior quarter.
• Over the last five years, Net Margin for FEED reached as high as 2018.63% in Q4 2022 and fell as low as 4366.35% in Q4 2025.
• Historically, Net Margin has averaged 559.51% across 5 years, with a median of 265.43% in 2024.
• Across the five-year window, Net Margin jumped 435178 bps in 2022 and plunged 404405 bps in 2025, its largest moves.
• Year by year, Net Margin stood at 2018.63% in 2022, then tumbled by 103 bps to 69.07% in 2023, then sank by 367 bps to 322.3% in 2024, then plunged by 1255 bps to 4366.35% in 2025, then climbed by 21 bps to 3464.17% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 3464.17% in Q1 2026, 4366.35% in Q4 2025, and 108.03% in Q3 2025.